T: +91 124 4708 700 |  E: info@knspartners.com    

         

         

         

Amrish Tiwari Represented the Indian Perspective at CIPF 2026 Pharmaceutical IP Session on November 6, 2026.

Events
Amrish participated virtually in the Pharmaceutical IP Session of the 2026 China International Patent Fair (CIPF), held in Wuxi, Jiangsu Province, China, on November 6, 2026. He represented the Indian perspective in discussions on pharmaceutical intellectual property.

Organized by the China National Intellectual Property Administration (CNIPA), the session brought together government officials, industry representatives and IP stakeholders to discuss China’s evolving pharmaceutical IP framework and its role in supporting biotechnology innovation. The discussions also covered lessons that other countries could draw from China’s experience in strengthening pharmaceutical innovation and improving patient access to innovative medicines.

DISCLAIMER

As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:

  • There has been no advertisement, personal communication, solicitation, invitation or inducement of any sort whatsoever from us or any of our members to solicit any work through this website;
  • The user wishes to gain more information about us for his/her own information and use;
  • The information about us is provided to the user only on his/her specific request and any information obtained or materials downloaded from this website is completely at the user’s volition and any transmission, receipt or use of this site would not create any lawyer-client relationship.

The information provided under this website is solely available at your request for informational purposes only, should not be interpreted as soliciting or advertisement. We are not liable for any consequence of any action taken by the user relying on material / information provided under this website. In cases where the user has any legal issues, he/she in all cases must seek independent legal advice.